Onkologie

Onkology

PROSENSE NEXT GENERATION CRYOABLATION TECHNOLOGY

Short treatment times (5-15 minutes)
Probes in various sizes, for targeted iceball
Safe and efficient probe design
Liquid nitrogen for maximum efficacy
Convenient and easy to use system

The procedure is fast, easy and comfortable; it can be completed in minutes, in the physician’s office, under ultrasound guidance. With minimal impact on the patient’s routine, cryoablation has a short recovery time, and leaves virtually no scarring.

IceSense3™ Probe

Various sizes, designed for tailoring the size of the ablation zone
Efficiency and safety maximized
Heat exchange mechanism located at tip to confine iceball and freezing to targeted zone
Vacuum insulation along length of probe further protects tissue and skin outside targeted zone of treatment
Disposable component is small

IceSense3™ Console

Convenient touch screen to customize the procedure for the individual patient
Unit controlled from console touch screen and buttons, handle, or foot pedal
Cryoablation system utilizes liquid nitrogen for efficient freeze-thaw-freeze cycles

IceSense3™ Cryoablation is a Fast, Easy, Comfortable Procedure

Simple, ultrasound-guided procedure
Rapid cryoablation
Office-based cryoablation is comfortable for patients
Patients report high satisfaction from treatment and results
Effective, durable procedure for treating fibroadenomas

Why is IceSense3™ Cryoablation a Compelling Treatment Option?

Immediate, safe, effective and durable lesion ablation in the office
No breast tissue is removed
No sutures required (steri-strip procedure)
Cryoablation creates cosmetically superior results — no cavity for hematoma formation or volume loss

More informations

Videos

MIRAâ„¢ Technology

MIRA utilizes dual-head proprietary Structured Light Projection Infrared imaging technology to construct 3-D vascular maps of the breasts.

Blood vessels are an essential part of solid cancers as they supply oxygen and nutrients. New vessels are also formed during cancer progression, a process that can further allow cancer growth and expansion. Therefore, assessment of cancer vascularity might provide information to characterize underlying malignancy. In the past decade, several studies have demonstrated the association between breast cancer and vascularity using contrast-enhanced MRI.

The MIRA technology can assess breast vascularity for likelihood of malignancy. The assessment is based on sophisticated multi-desciplinary machine learning technology, that provides the physician a Risk Assessment Score. The Risk Assessment Score has been clinically validated in a population of women with histology confirmed breast cancer.

More informations

Videos

Biop Medical

Biop Medical has developed a revolutionary hybrid/modular device for cervical cancer screening and diagnosis.

The device is comprised of the following components:

Biop's control unit
Biop's Digital Colposcope unit
Biop's Micro Colposcope Probe unit with a single-use, disposable cover
Dedicated computer with a proprietary software
Dedicated tripod (optional)

â€‹

The Device and its' Hybrid Operation

The Biop’s Micro- Colposcope Probe unit captures a macro-image of the cervix, using its macro-camera, before being brought to contact with the cervix. After contacting the cervix, the high-magnification camera scans the cervix and obtains high-resolution, high-magnification images within a radius of 11mm around the external os, which serves as the center of the scan.
This high-resolution data is then processed by a dedicated software that improves the image quality using common image enhancement methods, such as illumination field artifact removal and contrast enhancement.
The high-magnification images obtained by the probe unit are then registered with the panoramic images obtained by the Digital Colposcope unit (see registration details below). In addition, the high-magnification images are tiled into a single image of the entire scanned area, which s free of optical aberrations or tiling artifacts.